Author

admin

Browsing

Ukrainian President Volodymyr Zelenskyy heads into a high-stakes White House meeting with President Donald Trump on Monday, as Washington considers security guarantees for Kyiv and debate intensifies over whether land concessions to Russia could end the war.

Zelenskyy will be flanked by key European allies at the White House, a diplomatic overture that signals Europe’s determination to rally behind Ukraine.

Over the weekend, the Ukrainian leader acknowledged his last White House visit – cut short by a shouting match between Trump and Vice President JD Vance – and told reporters in Brussels he hopes Monday’s meeting ‘will be productive’ rather than a repeat of February’s encounter.

The upcoming meeting comes on the heels of Trump’s summit with Russian leader Vladimir Putin in Anchorage on Friday, where the U.S. leader shifted from demanding a ceasefire to calling for a final peace deal.

Trump’s special envoy Steve Witkoff told CNN that Putin agreed to allow the U.S. to provide Ukraine ‘robust security guarantees.’ 

‘We got to an agreement that the United States and other European nations could effectively offer Article 5-like language to cover a security guarantee,’ in reference to the critical NATO provision,’ Witkoff said, referencing the military alliance’s mutual defense clause, known as Article 5.

NATO’s Article 5 – the cornerstone of the alliance – stipulates that an attack on one member is an assault on all, obligating allies to come to each other’s defense. The proposed security guarantees for Ukraine would not come through NATO, but rather from select European allies in the event of a Russia-Ukraine peace deal.

Zelenskyy welcomed the revelation during a Sunday press conference alongside European Commission President Ursula von der Leyen.

‘It’s important that America agrees to work with Europe to provide security guarantees for Ukraine, and we are very thankful to the United States under the president for such a signal,’ Zelenskyy said.

‘This is a significant change, but there are no details about how it will work and what America’s role will be, what Europe’s role will be and what the EU can do,’ he added.

‘Impossible to give up territory or trade land’

Over the weekend, Zelenskyy reiterated that his war-weary nation will not surrender any territory to Russia as the Kremlin’s three-and-a-half-year conflict grinds on.

‘The constitution of Ukraine makes it impossible to give up territory or trade land,’ Zelenskyy said during a press conference at the EU Commission on Sunday. 

He added that Russia has repeatedly tried and failed to seize the entirety of the Donbas region in eastern Ukraine for a period of 12 years. 

The area, which includes Donetsk and Luhansk oblasts, is an industrial hub where coal mining and steel production remain central to Ukraine’s economy. In short, control of Donbas’s mines and factories would hand Moscow powerful leverage over Kyiv’s financial survival.

‘Since the territorial issue is so important, it should be discussed only by the leaders of Ukraine and Russia at the trilateral Ukraine, United States, Russia,’ Zelenskyy said.

The Ukrainian leader, who spoke alongside von der Leyen, said that so far the Kremlin has ‘given no sign that the trilateral will happen.’ 

‘With regards to any territorial questions in Ukraine, our position is clear: international borders cannot be changed by force. These are decisions to be made by Ukraine and Ukraine alone, and these decisions cannot be taken without Ukraine at the table,’ von der Leyen said.

Following the meeting with the Russian leader, Trump signaled that Zelenskyy should take Putin’s deal to end the war because ‘Russia is a very big power’ and Ukraine is not. Still, Secretary of State Marco Rubio sought to play down speculation that Trump could push Zelenskyy to give up Ukrainian land to Russia as part of a deal to end the war.

‘The president has said that in terms of territories, these are things that Zelenskyy is going to have to decide on,’ Rubio told Maria Bartiromo on Fox News’ ‘Sunday Morning Futures.’

‘All the president is trying to do here is narrow down the open issues,’ Rubio said, adding that Trump is focused on ending the Kremlin’s full-throttle assault on Ukraine.

This post appeared first on FOX NEWS

President Donald Trump fired off insults toward Sen. Chris Murphy, D-Conn., in a Sunday post on Truth Social in response to the senator’s criticism of his summit with Russian President Vladimir Putin.

The president described Murphy as ‘very unattractive (both inside and out),’ ‘stupid,’ and ‘a lightweight,’ after the senator claimed ‘Putin got everything he wanted’ during an appearance on NBC’s ‘Meet the Press.’

Murphy also described the meeting, which was held to broker peace between Ukraine and Russia, as ‘a disaster,’ ‘an embarrassment for the United States’ and ‘a failure.’

Murphy shared a clip of his appearance on his X account, captioning the video with more criticism of Trump’s meeting with Putin in Alaska on Friday.

‘The Putin-Trump meeting was a disaster, as predicted. Putin got everything he wanted: a photo op legitimizing his war crimes, no ceasefire, and no sanctions or new weapons for Ukraine. Trump’s goal was to keep Putin happy. He succeeded,’ Murphy wrote.

Trump pushed back, asserting in his Truth Social post, ‘The very unattractive (both inside and out!) Senator from Connecticut, Chris Murphy, said ‘Putin got everything that he wanted.’ Actually, ‘nobody got anything,’ too soon, but getting close. Murphy is a lightweight who thinks it made the Russian President look good in coming to America.

‘Actually, it was very hard for President Putin to do so. This war can be ended, NOW, but stupid people like Chris Murphy, John Bolton, and others, make it much harder to do so,’ he added.

Ukrainian President Volodymyr Zelenskyy and seven European leaders will meet with Trump in Washington, D.C. on Monday to continue seeking an end to the Russia-Ukraine war.

‘Big day at the White House tomorrow. Never had so many European Leaders at one time. My great honor to host them!!!’ Trump said in a separate Sunday night post on Truth Social.

In a third post on Sunday, Trump said Zelenskyy ‘can end the war with Russia almost immediately, if he wants to, or he can continue to fight.’ 

Trump continued, ‘Remember how it started. No getting back Obama given Crimea (12 years ago, without a shot being fired!), and NO GOING INTO NATO BY UKRAINE. Some things never change!!!’

This post appeared first on FOX NEWS

(TheNewswire)

Vancouver, British Columbia / September 11, 2025 ‑ TheNewswire – Harvest Gold Corporation (TSXV: HVG,OTC:HVGDF) (‘ Harvest Gold ‘ or the ‘ Company ‘) announces that, subject to the approval of the TSX Venture Exchange (the ‘ Exchange ‘), it has arranged a non-brokered private placement of up to 6,666,667 units of the Company (‘ Units ‘) at a price of $0.075 per Unit for aggregate gross proceeds of up to $500,000 (the ‘ Private Placement ‘).

Harvest Gold President and CEO, Rick Mark, states: ‘One of our investors in the recently completed Private Placement has asked if we would accept a larger investment with the same terms. The board of directors of the Company has approved the request as it will allow us to do prospecting, mapping and geo chemistry on areas in the southern part of Mosseau and on LaBelle with the goal of providing new drill targets this year. It also provides us flexibility should we wish to add meters to the current drill program at Mosseau.’

Each Unit will consist of one common share in the capital of the Company (each, a ‘ Share ‘) and one transferable common share purchase warrant (each, a ‘ Warrant ‘). Each Warrant will entitle the holder thereof to acquire one additional Share (each, a ‘ Warrant Share ‘) at a price of $0.12 per Warrant Share for a period of two years following the closing date of the Private Placement.

The Company anticipates using the proceeds from the Private Placement for exploration expenses on its properties in the Urban Barry area of Quebec, Canada, and general working capital.

All securities issued will be subject to a four-month hold period pursuant to securities laws in Canada and, where applicable.  Finders’ fees may be payable to qualified parties.

About Harvest Gold Corporation

Harvest Gold has three active gold projects focused in the Urban Barry area, totalling 329 claims covering 17,539.25 ha , located approximately 45-70 km east of the Gold Fields Windfall Deposit.

Harvest Gold acknowledges that the Mosseau Gold Project straddles the Eeyou Istchee-James Bay and Abitibi territories.  Harvest Gold is committed to developing positive and mutually beneficial relationships based on respect and transparency with local Indigenous communities.

ON BEHALF OF THE BOARD OF DIRECTORS

Rick Mark
President and CEO
Harvest Gold Corporation

For more information please contact:

Rick Mark or Jan Urata
@ 604.737.2303 or
info@harvestgoldcorp.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Information

This news release includes certain statements that may be deemed ‘forward looking statements’. All statements in this news release, other than statements of historical facts, that address events or developments that Harvest Gold expects to occur, are forward looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.

The securities referred to in this news release have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’), or any applicable securities laws of any state of the United States, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act) or persons in the United States unless registered under the U.S. Securities Act and any other applicable securities laws of the United States or an exemption from such registration requirements is available.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities within any jurisdiction, including the United States.  Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

NOT FOR DISTRIBUTION OR DISSEMINATION TO THE UNITED STATES

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Sen. John Fetterman, D-Pa., is continuing his streak of breaking with his party — this time on voter ID legislation gaining momentum in the Senate.

Senate Minority Leader Chuck Schumer, D-N.Y., and Senate Democrats have near-unanimously rejected the Safeguarding American Voter Eligibility (SAVE) Act, election integrity legislation that made its way through the House earlier this week.

Schumer has dubbed the legislation ‘Jim Crow 2.0,’ arguing it would suppress voters rather than encourage more secure elections.

But Fetterman, who has repeatedly rejected his party’s messaging and positions, pushed back on Schumer’s framing of the bill.

‘I would never refer to the SAVE Act as like Jim Crow 2.0 or some kind of mass conspiracy,’ Fetterman told Fox News’ Kayleigh McEnany on ‘Saturday in America.’

‘But that’s part of the debate that we were having here in the Senate right now,’ he continued. ‘And I don’t call people names or imply that it’s something gross about the terrible history of Jim Crow.’

The bill would require voters to present photo identification before casting ballots, require proof of citizenship in person when registering to vote and mandate states remove non-citizens from voter rolls.

Momentum is building among Republicans. Sen. Susan Collins, R-Maine, became the 50th member of the conference to back the legislation. But Senate Democrats have all but guaranteed its demise in the upper chamber, via the filibuster.

Fetterman would not say whether he supports the bill outright. However, he noted that ‘84% of Americans have no problem with presenting IDs to vote.’

‘So it’s not like a radical idea,’ Fetterman said. ‘It’s not something — and there already are many states that show basic IDs. So that’s where we are in the Senate.’

Even if Fetterman were to support the bill on the floor, it is unlikely to pass without more significant procedural changes.

There are currently not enough votes to overcome the Senate’s 60-vote filibuster threshold.

Fetterman is also not keen on eliminating the filibuster — a position shared by most Senate Republicans.

He noted that Senate Democrats once favored scrapping the filibuster but now want to preserve it while in the minority in a Republican-controlled government.

‘I campaigned on it, too,’ Fetterman said. ‘I mean we were very wrong about that to nuke the filibuster. And we should really humble ourselves and remind people that we wanted to eliminate it — and now we love it.’

This post appeared first on FOX NEWS

President Donald Trump’s foreign policy agenda is set to take center stage again this week, with Ukrainian President Volodymyr Zelenskyy visiting the White House on Monday as Washington continues efforts to broker peace between Moscow and Kyiv.

The upcoming meeting comes on the heels of Trump’s summit with Russian leader Vladimir Putin in Anchorage on Friday, where the U.S. leader shifted from demanding a ceasefire to calling for a final peace deal. Trump discussed some of the details of his meeting with Putin during a phone call with Zelenskyy from Air Force One.

The White House has yet to release details of the meeting but has acknowledged that key European allies will accompany Zelenskyy.

NATO Secretary General Mark Rutte, European Commission President Ursula von der Leyen, French President Emmanuel Macron, British Prime Minister Keir Starmer, German Chancellor Friedrich Merz, Italian Prime Minister Giorgia Meloni and Finnish President Alexander Stubb all confirmed their plans to attend.

Over the weekend, Zelenskyy acknowledged his last White House visit — cut short by a shouting match with both Trump and Vice President JD Vance — and told reporters in Brussels he hopes Monday’s meeting ‘will be productive’ rather than a repeat of February’s encounter.

Trump’s back-to-back meetings with both former Soviet republics could set the stage for a trilateral summit with the U.S., Russia and Ukraine.

Over the weekend, Zelenskyy said that, so far, Russia has ‘given no sign that the trilateral will happen.’ The Ukrainian leader also said over the weekend that he would use his meetings in Washington to stress that Kyiv will reject any peace deal with Moscow that undermines Ukraine’s sovereignty.

Trump signaled that Putin could agree to end the war if Zelenskyy ceded the entirety of the hotly-contested Donbas region to Russia. 

The area, which includes Donetsk and Luhansk oblasts, is an industrial hub where coal mining and steel production remain central to Ukraine’s economy. Control of Donbas’s mines and factories would hand Moscow powerful leverage over Kyiv’s post-war financial survival.

‘The constitution of Ukraine makes it impossible to give up territory or trade land,’ Zelenskyy said during a press conference at the EU Commission on Sunday. 

‘Since the territorial issue is so important, it should be discussed only by the leaders of Ukraine and Russia at the trilateral Ukraine, United States, Russia,’ Zelenskyy said.

Secretary of State Marco Rubio dismissed reports that Trump supports Russia’s conditions for peace.

‘The president has said that in terms of territories, these are things that Zelenskyy is going to have to decide on,’ Rubio told Maria Bartiromo on Fox News’ ‘Sunday Morning Futures.’

‘All the president is trying to do here is narrow down the open issues,’ Rubio said, adding that Trump remains focused on ending the Kremlin’s three-and-a-half-year war in Ukraine. 

This post appeared first on FOX NEWS

Further to its announcement on 20 October 20251, Jindalee Lithium Limited (ASX: JLL, OTCQX: JNDAF) (Company) is pleased to advise the results of its Share Purchase Plan (SPP). The SPP closed for applications on 20 November 2025, and the Company has today completed the allocation and issuance of shares and options under the SPP, raising total proceeds of $1.5 million.

The SPP, which targeted to raise up to $1 Million, was met with strong demand and closed oversubscribed. In accordance with the SPP Offer Booklet2, the Board exercised its discretion to accept oversubscriptions, resulting in total proceeds of $1.5 million. To ensure a fair allocation, applications for amounts greater than $5,000 were scaled back on a pro-rata basis. Excess application monies will be refunded to applicants in line with the SPP terms2.

A total of 2,720,065 fully paid ordinary shares (Shares) were issued at $0.55 per Share. Eligible shareholders also received one (1) option for every one (1) Share allotted, exercisable at $0.825 and expiring 30 November 2028 (Option), for nil upfront consideration. Participants in the placement announced on 20 October 2025 will also receive Options on the same basis as SPP participants, to be issued subject to shareholder approval at the Company’s general meeting to be held on 10 December 2025.

Funds raised will be used to advance the McDermitt Lithium Project, including exploration drilling, metallurgical testwork, and working capital to progress the proposed United States special purpose acquisition company (SPAC) transaction3.

Commenting on the SPP, Ian Rodger, the Company’s Managing Director and CEO, said “We are grateful for the outstanding support from our shareholders. The strong response to the SPP reflects confidence in Jindalee and the strategic importance of the McDermitt Project. On behalf of the Board, we thank you for your continued support.”

Click here for the full ASX Release

This post appeared first on investingnews.com

Discoveries made by companies in the genetics sector help support every other life science industry in a variety of ways.

One of the genetic sector’s major contributions is the discovery of new genetic drivers of diseases. Genetic testing has grown substantially over the last few years, thanks to advances in technology; growth has also been spurred by an increase in chronic diseases and the continuing development of test kits for therapeutic areas with unmet medical needs.

Gene therapy is also a huge driver of growth in the overarching genetics market. This important segment of the life science market is focused on how genes can help treat or prevent serious conditions in patients. This includes the potential for healthcare professionals to implement gene therapy at the cellular level instead of using medication or surgery, replacing ‘faulty’ genes with new ones to potentially cure diseases.

Pharma and biotech companies often dabble in genetics along with their core disciplines, meaning that some firms may also have operations in other areas.

The top NASDAQ genetics stocks listed below have products related to gene therapy, genetic testing, genetically defined cancers and rare genetic diseases.

Data for this list of genetics stocks on the NASDAQ was collected on December 31, 2025, using TradingView’s stock screener, and stocks with market caps above US$50 million were considered.

1. Avidity Biosciences (NASDAQ:RNA)

Year-over-year gain: 143.8 percent
Market cap: US$10.87 billion
Share price: US$72.14

Avidity Bioscience is a biopharma firm developing a new form of RNA therapy called antibody oligonucleotide conjugates (AOC) that target the genes causing rare muscle diseases.

Through its proprietary AOC platform, Avidity developed programs for three rare muscle diseases: AOC 1001 for myotonic dystrophy type 1, AOC 1044 for Duchenne muscular dystrophy and AOC 1020 for facioscapulohumeral muscular dystrophy. The company is also working to expand its pipeline into cardiology and immunology.

In October 2025, Avidity entered into a definitive agreement to be acquired by Novartis (NYSE:NVS), which will include the company’s late-stage neuromuscular programs (AOC 1001, 1020, 1044) and the AOC platform, for US$12 billion.

Avidity’s early-stage precision cardiology programs will spin off into a new public company prior to closing in H1 2026. The spin-off will also have rights to use and develop the AOC platform for cardiology applications.

2. Wave Life Sciences (NASDAQ:WVE)

Year-over-year gain: 36.52 percent
Market cap: US$3.13 billion
Share price: US$17.12

Wave Life Sciences is another clinical-stage firm focused on unlocking insights from human genetics to deliver RNA-based medicines. The company’s PRISM platform is targeting both rare and prevalent disorders. Its pipeline includes clinical programs for Duchenne muscular dystrophy, alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program for WVE-007 in obesity.

Wave Life Sciences advanced its PRISM RNA platform across multiple programs in 2025. It is also performing a Phase 1 trial testing its WVE-007 obesity candidate, which is an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design.

In December, the company reported positive interim data from the WVE-007 trial, which showed that a single dose resulted in sustained Activin E reduction, supporting infrequent dosing. Target engagement updates and body composition readouts are planned for Q1 2026.

3. UniQure (NASDAQ:QURE)

Year-over-year gain: 33.15 percent
Market cap: US$1.47 billion
Share price: US$23.86

UniQure is a gene therapy company focused on patients with severe medical needs. In November 2022, the US Food and Drug Administration (FDA) approved the company’s gene therapy Hemgenix (etranacogene dezaparvovec), which is the world’s first gene therapy for hemophilia B.

Today, uniQure’s proprietary gene therapy pipeline includes treatments for patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS and Fabry disease.

Its gene therapy pipeline advanced in 2025, with positive Phase I/II topline data for Huntington’s disease candidate AMT-130 showing 75 percent slowing of disease progression at three years via cUHDRS, alongside 60 percent functional capacity preservation.

While data from the Phase I/II study led the FDA to grant AMT-130 breakthrough therapy designation in April, in December the agency told UniQure it believes the data may not be adequate to support a pre-biologics license application under the accelerated approval pathway. The company is pursuing a follow-up meeting.

4. Stoke Therapeutics (NASDAQ:STOK)

Year-over-year gain: 186.96 percent
Market cap: US$1.81 billion
Share price: US$31.74

Stoke Therapeutics is another biotech company with a focus on developing RNA medicine. With its proprietary research platform TANGO, which stands for targeted augmentation of nuclear gene output, the company is developing antisense oligonucleotides to selectively restore protein levels.

Stoke’s first product candidate, zorevunersen (STK-001), is in clinical testing for the treatment of Dravet syndrome, a severe form of genetic epilepsy. The company is also developing STK-002 for the treatment of autosomal dominant optic atrophy, an inherited optic nerve disorder.

Both candidates advanced in 2025, with STK-001 enrolling patients in Phase 3 after positive long-term data showed seizure reductions and cognitive gains. Likewise, STK-002’s clinical development program is being informed by results, presented in October, of a Phase 1 two year natural history study on the disease progression of autosomal dominant optic atrophy.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to provide an update on the Phase I drilling program at its La Union Gold and Silver project in northwest Sonora, Mexico. Drill holes have now been completed at two of the 4 target areas:

  • The initial hole was completed beneath the historic Union Mine itself, intersecting the favourable carbonaceous Clemente and Caborca formations, including the microconglomeratic carbonate unit which hosted mineralization at the bottom of the past producing Union Mine.
  • Drilling then shifted focus to the El Cobre Mine area and the Union Norte Mine area, testing vertical feeder zones above the Clemente formation dolomites and carbonaceous sandstones. Hole two intersected more quartzites than interpreted from the geophysics, with the quartzites carrying more extensive hematitic oxides, possibly indicative of oxide gold mineralization potentially related to sulfides which have been oxidized through supergene weathering.

Saf Dhillon, President and Chief Executive Officer, states: ‘The drilling is indicating oxidation is consistent with past mining and targets are coming along with a positive exploration drilling so far. The drilling is intersecting more quartzite than expected which is favorable for fracture-controlled mineralization. The Riverside operations team is progressing the current exploration program working with the surface rancher and the drilling company to efficiently progress a high-quality exploration program.’

Drilling has now moved to the Famosa Target to progress exploration program. The Mexico Mining Ministry has approved many permits and are actively supporting the environmentally, socially conscious mineral exploration practices as a key aspect for the new Mexican government initiatives.

The technical content of this news release has been reviewed and approved by R. Tim Henneberry’, P.Geo (BC) a Director of the Company and a Qualified Person under National Instrument 43-101.

About Questcorp Mining Inc.

Questcorp Mining is engaged in the business of the acquisition and exploration of mineral properties in North America, with the objective of locating and developing economic precious and base metals properties of merit. The company holds an option to acquire an undivided 100-per-cent interest in and to mineral claims totalling 1,168.09 hectares comprising the North Island copper property, on Vancouver Island, B.C., subject to a royalty obligation. The company also holds an option to acquire an undivided 100-per-cent interest in and to mineral claims totalling 2,520.2 hectares comprising the La Union project located in Sonora, Mexico, subject to a royalty obligation.

ON BEHALF OF THE BOARD OF DIRECTORS,

Saf Dhillon
President & CEO

Questcorp Mining Inc.
saf@questcorpmining.ca
Tel. (604-484-3031)

Suite 550, 800 West Pender Street
Vancouver, British Columbia
V6C 2V6.

Certain statements in this news release are forward-looking statements, which reflect the expectations of management regarding completion of survey work at the North Island Copper project. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Except as required by the securities disclosure laws and regulations applicable to the Company, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265741

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com